Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 7
1998 4
1999 4
2000 4
2001 4
2002 3
2003 4
2004 4
2005 8
2006 3
2007 8
2008 8
2009 4
2010 2
2011 10
2012 12
2013 11
2014 10
2015 11
2016 10
2017 10
2018 10
2019 14
2020 12
2021 22
2022 15
2023 5
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Results by year

Filters applied: . Clear all
Page 1
Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis.
Hindy G, Tyrrell DJ, Vasbinder A, Wei C, Presswalla F, Wang H, Blakely P, Ozel AB, Graham S, Holton GH, Dowsett J, Fahed AC, Amadi KM, Erne GK, Tekmulla A, Ismail A, Launius C, Sotoodehnia N, Pankow JS, Thørner LW, Erikstrup C, Pedersen OB, Banasik K, Brunak S, Ullum H, Eugen-Olsen J, Ostrowski SR; DBDS Consortium; Haas ME, Nielsen JB, Lotta LA; Regeneron Genetics Center; Engström G, Melander O, Orho-Melander M, Zhao L, Murthy VL, Pinsky DJ, Willer CJ, Heckbert SR, Reiser J, Goldstein DR, Desch KC, Hayek SS. Hindy G, et al. Among authors: eugen olsen j. J Clin Invest. 2022 Dec 15;132(24):e158788. doi: 10.1172/JCI158788. J Clin Invest. 2022. PMID: 36194491 Free PMC article.
Effects of 1 year of exercise training versus combined exercise training and weight loss on body composition, low-grade inflammation and lipids in overweight patients with coronary artery disease: a randomized trial.
Pedersen LR, Olsen RH, Anholm C, Astrup A, Eugen-Olsen J, Fenger M, Simonsen L, Walzem RL, Haugaard SB, Prescott E. Pedersen LR, et al. Among authors: eugen olsen j. Cardiovasc Diabetol. 2019 Oct 1;18(1):127. doi: 10.1186/s12933-019-0934-x. Cardiovasc Diabetol. 2019. PMID: 31575375 Free PMC article. Clinical Trial.
suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injury.
Nusshag C, Wei C, Hahm E, Hayek SS, Li J, Samelko B, Rupp C, Szudarek R, Speer C, Kälble F, Schaier M, Uhle F, Schmitt FC, Fiedler MO, Krautkrämer E, Cao Y, Rodriguez R, Merle U, Eugen-Olsen J, Zeier M, Weigand MA, Morath C, Brenner T, Reiser J. Nusshag C, et al. Among authors: eugen olsen j. JCI Insight. 2023 Apr 10;8(7):e165740. doi: 10.1172/jci.insight.165740. JCI Insight. 2023. PMID: 37036003 Free PMC article.
suPAR: A New Biomarker for Cardiovascular Disease?
Hodges GW, Bang CN, Wachtell K, Eugen-Olsen J, Jeppesen JL. Hodges GW, et al. Among authors: eugen olsen j. Can J Cardiol. 2015 Oct;31(10):1293-302. doi: 10.1016/j.cjca.2015.03.023. Epub 2015 Mar 25. Can J Cardiol. 2015. PMID: 26118447 Review.
suPAR: the molecular crystal ball.
Thunø M, Macho B, Eugen-Olsen J. Thunø M, et al. Among authors: eugen olsen j. Dis Markers. 2009;27(3):157-72. doi: 10.3233/DMA-2009-0657. Dis Markers. 2009. PMID: 19893210 Free PMC article. Review.
suPAR - a future risk marker in bacteremia.
Eugen-Olsen J. Eugen-Olsen J. J Intern Med. 2011 Jul;270(1):29-31. doi: 10.1111/j.1365-2796.2011.02372.x. Epub 2011 Mar 24. J Intern Med. 2011. PMID: 21366732 Free article. No abstract available.
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.
Kyriazopoulou E, Poulakou G, Milionis H, Metallidis S, Adamis G, Tsiakos K, Fragkou A, Rapti A, Damoulari C, Fantoni M, Kalomenidis I, Chrysos G, Angheben A, Kainis I, Alexiou Z, Castelli F, Serino FS, Tsilika M, Bakakos P, Nicastri E, Tzavara V, Kostis E, Dagna L, Koufargyris P, Dimakou K, Savvanis S, Tzatzagou G, Chini M, Cavalli G, Bassetti M, Katrini K, Kotsis V, Tsoukalas G, Selmi C, Bliziotis I, Samarkos M, Doumas M, Ktena S, Masgala A, Papanikolaou I, Kosmidou M, Myrodia DM, Argyraki A, Cardellino CS, Koliakou K, Katsigianni EI, Rapti V, Giannitsioti E, Cingolani A, Micha S, Akinosoglou K, Liatsis-Douvitsas O, Symbardi S, Gatselis N, Mouktaroudi M, Ippolito G, Florou E, Kotsaki A, Netea MG, Eugen-Olsen J, Kyprianou M, Panagopoulos P, Dalekos GN, Giamarellos-Bourboulis EJ. Kyriazopoulou E, et al. Among authors: eugen olsen j. Nat Med. 2021 Oct;27(10):1752-1760. doi: 10.1038/s41591-021-01499-z. Epub 2021 Sep 3. Nat Med. 2021. PMID: 34480127 Free PMC article. Clinical Trial.
Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI.
Azam TU, Shadid HR, Blakely P, O'Hayer P, Berlin H, Pan M, Zhao P, Zhao L, Pennathur S, Pop-Busui R, Altintas I, Tingleff J, Stauning MA, Andersen O, Adami ME, Solomonidi N, Tsilika M, Tober-Lau P, Arnaoutoglou E, Keitel V, Tacke F, Chalkias A, Loosen SH, Giamarellos-Bourboulis EJ, Eugen-Olsen J, Reiser J, Hayek SS; International Study of Inflammation in COVID-19. Azam TU, et al. Among authors: eugen olsen j. J Am Soc Nephrol. 2020 Nov;31(11):2725-2735. doi: 10.1681/ASN.2020060829. Epub 2020 Sep 22. J Am Soc Nephrol. 2020. PMID: 32963090 Free PMC article.
209 results